The Registry

The Registry

The ISAR initiative will provide support for data collection across all participating countries. The fully developed ISAR EDC system running on the CISIV platform is freely available to countries participating with the ISAR registry.

The ISAR registry includes the following data areas:

  • Patient details
  • Occupation
  • Comorbidity
  • Medical
    History
  • Blood/Sputum
  • Diagnostics
  • Lung function
  • Allergen
    testing
  • Asthma Control
  • Asthma Medication
  • Adherence
  • Treatment Management Plan

Current National Registries

Countries with existing and well established registries will be supported with extractions of the required data from their home registries for ISAR.

The existing registries include:

CountryRegistryOrganisationLink
UKSevere Asthma RegistryBritish Thoracic SocietyView
GermanyGerman Asthma Net (GAN)German Asthma NetView
ItalySevere/Uncontrolled Asthma Registry (SUA)Italian Severe Asthma Network(SANI)View
AustraliaSAWD Severe Asthma Web based DatabaseAustralasian Severe Asthma Network(ASAN)View

ISAR Progression to Date

Linking Severe Asthma Registries to Primary Care Electronic Health Records

United Kingdom

The Optimum Patient Care Research Database (OPCRD) is a bespoke database with focus on patient-reported outcomes that contains anonymous data from over 600 UK general practices across England, Scotland, Wales, and Northern Ireland. The database contains both longitudinal medical records and, for approximately 10% of patients with asthma and COPD, the results of patient-completed questionnaires. Hashed NHS identifiers can be obtained for all patients in this database during the anonymised data extraction process. The ability to link severe asthma registry data with data in primary care databases such as the OPCRD, will be an added advantage and allow in-depth characterisation of:

  • Healthcare resource use
  • Medical history and comorbidities
  • Medication use, including adherence and persistence

To learn more about the OPCRD please click here.